External Defibrillator Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

External Defibrillator Market Trends & Growth Drivers

Shift toward External Defibrillators from Implantable Ones Is Major Trend

• In addition to the emerging use of AEDs in public access settings, healthcare professionals are shifting focus from implantable cardioverter defibrillator (ICD) to external defibrillators.
• This is owing to the rising risks of blood vessel damage from ICD leads and bleeding around the heart, which can be life-threatening.
• Despite ICDs’ use in patients at a high risk of sustained or recurrent arrhythmia, the use of external defibrillators is gaining popularity, especially for older patients who cannot undergo heart surgeries.
• Moreover, external defibrillator is also being increasingly used to monitor and deliver a shock to patients encountering irregular heart rhythms.

Surging Geriatric Population Drives Industry

• The increasing population of elderly people is one of the key factors driving the global external defibrillator market.
• According to the World Health Organization, an estimated 17.9 million people die from CVDs every year, representing 32% of all global deaths. Of these deaths, 85% are due to heart attacks and strokes.
• Additionally, as per the Centers for Disease Control and Prevention (CDC), in the U.S., 14.2% of the adults aged 45 years and older report coronary heart disease (CHD) or a stroke, or both.
• Further, 11.6% of the adults diagnosed with CHD or a stroke or both, aged 65 years and older, report 14 or more mentally unhealthy days in a month, compared to 27.8% of the adults aged 45–64 years.
• With the increase in age, elderly people tend to become susceptible to chronic diseases, majorly CVDs.
• SCA is the major cause of mortality of the elderly in the U.S., owing to the high prevalence of coronary heart disease (CHD), systolic dysfunction, and congestive heart failure (CHF).
• Also, there is a direct co-relation between SCA and age (i.e., the incidence of SCA increases with age). Thus, with the surging number of elderly people, the demand for external defibrillators is increasing, globally.

Stringent Compliance Regulations Hamper Market Advance

• The majority of the countries have stringent regulatory frameworks for external defibrillators, which may hamper the market growth to some extent.
• In February 2021, to assure the quality and reliability of AEDs, the United States Food and Drug Administration (USFDA) ordered the filing of premarket approval (PMA) applications for all previously approved necessary accessories (such as batteries, pad electrodes, adapters) for the operation of AEDs.
• The PMA process helps the USFDA to review the quality of the systems and their manufacturing information.
• The USFDA conducts pre-approval inspections, reviews changes in manufacturing facilities, and inspects design and manufacturing changes that affect the safety and effectiveness of the devices to ensure that the products are adequately evaluated and tested prior to being marketed.
• Moreover, current good manufacturing practices (CGMPs) play a major role in the approval of cardiac defibrillators. For instance, in November 2017, the USFDA reached an agreement with Koninklijke Philips N.V. (Philips) to prohibit its subsidiary Philips Medical Systems Ltd. from manufacturing, processing, holding, or distributing AEDs from their Andover (Massachusetts) and Bothell (Washington) facilities over quality control issues.
• The agency found that Philips Medical System Ltd. manufactured and distributed adulterated devices and its AED manufacturing violated CGMP requirements under the Federal Food, Drug, and Cosmetic (FD&C) Act based on non-compliance with quality system (QS) regulations.
• Thus, due to strict investigation from regulatory authorities, existing market players and new companies entering the external defibrillator market are required to follow stringent standards and invest huge capital for the manufacturing and commercialization of these devices, while complying with CGMPs and ensuring user safety.

External Defibrillator Market Analysis

Patient Type Insights

In 2024, adult patients account for the larger revenue share, of 65%, and this category will also witness the higher CAGR, of 8.7%, over this decade.

With the increasing number of adult patients in comparison to pediatric patients all over the world, the risk of CVDs is increasing. Adults are more prone toward cardiac diseases due to unhealthy lifestyles. Moreover, as age increases, the immune system of an individual started facing problems while fighting diseases. Moreover, each year, approximately 0.1% of the U.S. population experience a medical services-assessed, OHCA. The European region has a similar incidence, ranging from 0.04% to 0.1% of the population.

We have covered the following patient types

• Adult (Larger and Faster-Growing Category)
• Pediatric

End User Insights

The public access settings category dominates the market in 2024, with around 50% revenue share. This category will also witness the fastest growth, at a CAGR of 8.9%, during the forecast period.

The rise in the incidence of SCAs and mandate availability of automated external defibrillators in public access settings are key factors contributing to the growth of the market in this end-user category. For example, the U.S., as well as a number of European and APAC countries, has established legislation requiring the installation of these devices in public spaces. These devices have been implemented in public locations such as community centers, schools, stadiums, health clubs, recreation centers, shopping centers, transportation centers, government buildings, airlines, and offices, as a result of this.

The report offers insights for the following end users:

• Hospitals, Clinics, and Cardiac Centers
• Pre-Hospital Care and Emergency Medical Service (EMS) Providers
• Public Access Settings (Largest and Fastest-Growing Category)
• Homecare Settings

Regional Analysis

North America Is Largest and Fastest-Growing Market

In 2024, North America holds the major revenue share, of around 45%, in the market. This region will also grow at the highest rate, of 9.0%, during 2024–2030.

The market in North America is mainly driven by the rising healthcare spending, increasing prevalence of CVDs, surging geriatric population, and growing awareness of the benefits of external defibrillators in the event of VF and pulseless ventricular tachycardia.

For instance, the U.S. government spends a significant portion of its GDP on healthcare every year. According to the National Health Expenditure Accounts (NHEA), the country’s healthcare spending increased to 9.7% (around USD 4.1 trillion) in 2020, from 4.3% in 2019. Furthermore, the NHEA states that the country’s healthcare spending is projected to reach USD 6.0 trillion by 2027, and it is expected to grow at a CAGR of 5.5% during 2022–2030.

Besides, conferences, national programs, and other government initiatives for creating awareness on CVDs are expected to positively impact the market in the North American region. For instance, The American Society for Preventative Cardiology Congress on CVD Prevention will be held in Salt Lake City, Utah, on August 2–4. Similarly, the Canadian Cardiovascular Congress (CCC) 2024 is scheduled for October 24–27 in Vancouver, British Columbia.

The Indian market is expected to grow at a significant pace during the forecast period. The market is primarily driven by several measures taken by public and private organizations to raise awareness about these devices, rise in healthcare expenditure, and strategic developments among market players.

As per government sources, the per-capita healthcare spending in India rose from INR 4,470 in 2019 to INR 4,863 in 2023, while the total healthcare expenditure increased from INR 5,96,440 crore to INR 6,55,822 crore. This indicates that healthcare facilities are adopting technological advancements, thereby driving the external defibrillator market in the country.

The LATAM and Caribbean regions have made strides toward universal health coverage by providing affordable healthcare services to people. Thus, with the rise in healthcare expenditure and health coverage, it is likely that the demand for these devices will also increase in the future. Further, the per capita income of people in the LATAM region has improved over the years, which will boost the market growth in the coming years. For instance, as per the International Monetary Fund, the GDP per capita in Brazil is around USD 1,135,000 in 2024.

Moreover, in Brazil, the cases of heart diseases are increasing. Obesity and overweight are the key factors responsible for heart diseases, CVD, CDH, HF, and stroke. Also, it is an emerging economy and has an improved healthcare system with quality care and low cost of surgeries. Thus, the Government of Brazil is promoting the adoption of defibrillators and creating awareness about life-threatening diseases.

The following regions and countries are covered in the report:

• North America (Largest and Fastest-Growing Regional Market)
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe
  • Germany (Largest and Fastest-Growing Country Market)
  • France
  • Italy
  • Spain
  • U.K.
  • Russia
  • Netherlands
  • Belgium
  • Ireland
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan (Largest and Fastest-Growing Country Market)
  • India
  • Australia
  • South Korea
  • Thailand
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest and Fastest-Growing Country Market)
  • South Africa
  • Rest of MEA

External Defibrillator Market Share

The external defibrillator market is fragmented on account of the availability of different types of products for different needs and varying regulatory scenario across countries. Additionally, the players target a range of end users for their products, such as clinics, public areas, hospitals, homecare settings, and nursing homes. Moreover, companies use many channels to reach customers, such as direct sales, online platforms, and third-party distributors.

External Defibrillator Market News

• In June 2024, Koninklijke Philips N.V. launched its Cardiac Workstation as a supplementary digital platform for its ECG management solutions. This EMR-integrated solutions can work in tandem with the Philips IntelliSpace ECG management system, allowing clinicians to analyze heart rhythms remotely and make more-informed care decisions.
• In June 2024, Stryker Corporation expanded its R&D facility in India to make it a center for the lifecycle testing of a range of medical devices.
• In June 2024, Stryker Corporation launched the LIFEPAK 35 monitor/defibrillator.
•  In November 2023, Nihon Koden Corporation announced plans to establish a new sales subsidiary in Vietnam, which was to start operations by March 2024.